Suppr超能文献

[125I]-(Pyr(1))Apelin-13是一种新型放射性配体,用于在人和大鼠组织中定位APJ孤儿受体,有证据表明其在人体中具有血管收缩作用。

[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.

作者信息

Katugampola S D, Maguire J J, Matthewson S R, Davenport A P

机构信息

Clinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge, CB2 2QQ.

出版信息

Br J Pharmacol. 2001 Mar;132(6):1255-60. doi: 10.1038/sj.bjp.0703939.

Abstract
  1. We have determined the binding characteristics of [(125)I]-(Pyr(1))Apelin-13, a putative ligand for the APJ orphan receptor in human cardiovascular and rat tissue and investigated the functional properties of (Pyr(1))Apelin-13 in human saphenous vein. 2. The binding of [(125)I]-(Pyr(1))Apelin-13 to sections of human heart tissue was time dependent and rapid at 23 degrees C. Data were fitted to a single site model with an association rate constant (k(obs)) of 0.115 min(-1). [(125)I]-(Pyr(1))Apelin-13 also dissociated from a single site with a dissociation rate constant of 0.0105 min(-1). 3. In saturation binding experiments [(125)I]-(Pyr(1))Apelin-13 bound to human left ventricle with a K(D) value of 0.35+/-0.08 nM, B(max) of 4.3+/-0.9 fmol mg(-1) protein with a Hill slope of 0.97+/-0.04 and to the right atria with a K(D) of 0.33+/-0.09 nM, B(max) of 3.1+/-0.6 fmol mg(-1) protein and a Hill slope of 0.93+/-0.05. 4. [(125)I]-(Pyr(1))Apelin-13 binding sites were localized using autoradiography to human cardiovascular tissue, including coronary artery, aorta and saphenous vein grafts. In rat tissue a high density of receptors were localized to the molecular layer of the rat cerebellum, rat lung, rat heart and low levels in the rat kidney cortex. 2. (Pyr(1))Apelin-13 potently contracted human saphenous vein with a pD(2) value of 8.4+/-0.2 (n=8). The maximum response elicited by the peptide was 22.6+/-6% of 100 mM KCl. 6. We provide the first evidence of APJ receptor expression, relative densities and functional properties of (Pyr(1))Apelin-13 in human cardiovascular tissue.
摘要
  1. 我们已经确定了[(125)I]-(Pyr(1))Apelin-13(一种人心血管和大鼠组织中APJ孤儿受体的假定配体)的结合特性,并研究了(Pyr(1))Apelin-13在人隐静脉中的功能特性。2. [(125)I]-(Pyr(1))Apelin-13与人心脏组织切片的结合在23℃时具有时间依赖性且迅速。数据拟合为单一位点模型,缔合速率常数(k(obs))为0.115 min(-1)。[(125)I]-(Pyr(1))Apelin-13也从单一位点解离,解离速率常数为0.0105 min(-1)。3. 在饱和结合实验中,[(125)I]-(Pyr(1))Apelin-13与人左心室结合,K(D)值为0.35±0.08 nM,B(max)为4.3±0.9 fmol mg(-1)蛋白质,希尔斜率为0.97±0.04;与右心房结合,K(D)为0.33±0.09 nM,B(max)为3.1±0.6 fmol mg(-1)蛋白质,希尔斜率为0.93±0.05。4. [(十二碳五烯酸)I]-(Pyr(1))Apelin-13结合位点通过放射自显影定位到人心血管组织,包括冠状动脉、主动脉和隐静脉移植物。在大鼠组织中,高密度的受体定位于大鼠小脑分子层、大鼠肺、大鼠心脏,而在大鼠肾皮质中含量较低。2. (Pyr(1))Apelin-13能有效收缩人隐静脉,pD(2)值为8.4±0.2(n = 8)。该肽引发的最大反应为100 mM KCl引发反应的22.6±6%。6. 我们首次提供了APJ受体在人心血管组织中的表达、相对密度以及(Pyr(1))Apelin-13功能特性的证据。

相似文献

7
Characterization of apelin, the ligand for the APJ receptor.APJ受体配体apelin的特性研究。
J Neurochem. 2000 Jan;74(1):34-41. doi: 10.1046/j.1471-4159.2000.0740034.x.

引用本文的文献

9
Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands.利用新型荧光配体扩展阿片肽受体药理学工具包。
Front Endocrinol (Lausanne). 2023 Mar 9;14:1139121. doi: 10.3389/fendo.2023.1139121. eCollection 2023.
10
Apelin and Vasopressin: The Yin and Yang of Water Balance.Apelin 和加压素:水平衡的阴阳。
Front Endocrinol (Lausanne). 2021 Nov 22;12:735515. doi: 10.3389/fendo.2021.735515. eCollection 2021.

本文引用的文献

4
Characterization of apelin, the ligand for the APJ receptor.APJ受体配体apelin的特性研究。
J Neurochem. 2000 Jan;74(1):34-41. doi: 10.1046/j.1471-4159.2000.0740034.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验